These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10654876)

  • 1. Which organic acids does hemofiltrate contain in the presence of acute renal failure?
    Guth HJ; Zschiesche M; Panzig E; Rudolph PE; Jäger B; Kraatz G
    Int J Artif Organs; 1999 Dec; 22(12):805-10. PubMed ID: 10654876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which amino-acids do serum and hemofiltrate of critically ill patients with acute renal failure contain?
    Guth HJ; Wiersbitzky M; Ziesche M; Rose HJ; Kraatz G
    Int J Artif Organs; 1997 Jun; 20(6):309-15. PubMed ID: 9259206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of factor-VII and -XIII activity in ultrafiltrate during hemofiltration.
    Guth HJ; Klingbeil A; Wiedenhöft I; Rose HJ; Kraatz G
    Int J Artif Organs; 1999 Jul; 22(7):482-7. PubMed ID: 10493555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration.
    Krueger WA; Neeser G; Schuster H; Schroeder TH; Hoffmann E; Heininger A; Dieterich HJ; Forst H; Unertl KE
    Chemotherapy; 2003 Dec; 49(6):280-6. PubMed ID: 14671427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of continuous veno-venous haemofiltration in critically ill patients.
    Sorkine P; Halpern P; Scarlat A; Weinbroum A; Silbiger A; Setton A; Rudick V
    Clin Intensive Care; 1994; 5(6):293-5. PubMed ID: 10150557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients.
    Liu Y; Ouyang B; Chen J; Chen M; Ma J; Wu J; Huang S; Li L; Liu Z; Guan X
    Chin Med J (Engl); 2014; 127(10):1827-32. PubMed ID: 24824239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous veno-venous hemofiltration in acute renal insufficiency and heart failure].
    Tortorella G; Gonzi G; Zambrelli P; Cabassi A; Borghetti A; Fiaccadori E
    Cardiologia; 1997 Aug; 42(8):845-8. PubMed ID: 9312410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protein loss in critically ill patients during continuous veno-venous hemofiltration].
    Tang XY; Ren JA; Gu GS; Chen J; Fan YP; Li JS
    Zhonghua Wai Ke Za Zhi; 2010 Jun; 48(11):830-3. PubMed ID: 21163051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoactive substances eliminated by continuous venovenous hemofiltration in acute renal failure patients.
    Riegel W; Habicht A; Ulrich C; Köhler H
    Kidney Int Suppl; 1999 Nov; (72):S67-70. PubMed ID: 10560809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of amikacin during continuous veno-venous hemofiltration.
    Armendariz E; Chelluri L; Ptachcinski R
    Crit Care Med; 1990 Jun; 18(6):675-6. PubMed ID: 2344762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous veno-venous hemofiltration in Bhumibol Adulyadej Hospital.
    Chuasuwan A; Gojaseni P; Chittinandana A
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S86-97. PubMed ID: 17044459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration.
    Kroh UF; Lennartz H; Edwards DJ; Stoeckel K
    J Clin Pharmacol; 1996 Dec; 36(12):1114-9. PubMed ID: 9013367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of gamma-hydroxybutyric acid, DL-lactic acid, glycolic acid, ethylene glycol and other glycols in body fluids by a direct injection gas chromatography-mass spectrometry assay for wide use.
    Van Hee P; Neels H; De Doncker M; Vrydags N; Schatteman K; Uyttenbroeck W; Hamers N; Himpe D; Lambert W
    Clin Chem Lab Med; 2004; 42(11):1341-5. PubMed ID: 15576294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of separated system continuous venovenous hemofiltration in critical acute kidney injury.
    Susantitaphong P; Tiranathanagul K; Srisawat N; Katavetin P; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Oct; 15(5):475-80. PubMed ID: 21974701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood lactic acid level and APACHE II score on prognosis of critically ill elderly patients].
    Bao B; Li ZG; Sun XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Apr; 33(4):428-30. PubMed ID: 22781420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between blood lactic level, lactic clearance, duration of lacticemia and prognosis of critically ill patients in intensive care unit].
    Wang H; Wu DW; Chen XM; Li C; Ding SF; Zhai Q; Du BF; Li Y; Wang KF
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):357-60. PubMed ID: 19570343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial redox state in the critically ill.
    Yassen KA; Galley HF; Lee A; Webster NR
    Br J Anaesth; 1999 Aug; 83(2):325-7. PubMed ID: 10618950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
    Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.